当前位置: 首页 >> 检索结果
7721. Infliximab and leflunomide combination therapy in rheumatoid arthritis: an open-label study.
To study the safety and efficacy of infliximab plus leflunomide combination therapy in adult rheumatoid arthritis (RA).
7722. The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation.
To identify the pathogenetic mechanisms of central nervous system (CNS) syndromes of systemic lupus erythematosus (SLE) as described in the literature.
7723. The central nervous system in systemic lupus erythematosus. Part 1. Clinical syndromes: a literature investigation.
To establish the central nervous system (CNS) manifestations of systemic lupus erythematosus (SLE) as described in the literature and to compare the results with two previously published classifications.
7735. Predictors of survival and organ damage in Wegener's granulomatosis.
To determine survival, organ damage and predictors of these outcomes in a population-based, longitudinal cohort study of patients with Wegener's granulomatosis (WG).
7736. Risk factors for developing systemic lupus erythematosus: a case-control study in southern Sweden.
作者: A A Bengtsson.;L Rylander.;L Hagmar.;O Nived.;G Sturfelt.
来源: Rheumatology (Oxford). 2002年41卷5期563-71页
To explore the risk factors that have been suggested to be associated with the development of SLE.
7737. Macrophage migration inhibitory factor in rheumatoid arthritis: clinical correlations.
作者: E F Morand.;M Leech.;H Weedon.;C Metz.;R Bucala.;M D Smith.
来源: Rheumatology (Oxford). 2002年41卷5期558-62页
Cytokines play an important role in the pathology of rheumatoid arthritis (RA). Macrophage migration inhibitory factor (MIF) is a cytokine with a broad spectrum of actions, including induction of monocyte tumour necrosis factor alpha (TNF-alpha). Evidence of the expression and proinflammatory activity of MIF has recently been demonstrated in RA synovium and in animal models of RA. We wished to assess the relationship between MIF expression in synovium and clinical disease.
7738. Articular mobility in Maori and European New Zealanders.
To determine the prevalence of hypermobility and of the hypermobility syndrome (HMS) in Maori and European New Zealanders.
7739. Value of autoantibodies to beta(2)-glycoprotein 1 in the diagnosis of antiphospholipid syndrome.
作者: M A P Audrain.;D El-Kouri.;M A Hamidou.;L Mioche.;A Ibara.;M-L Langlois.;J-Y Muller.
来源: Rheumatology (Oxford). 2002年41卷5期550-3页
To define the specificity and positive predictive value of anti-beta(2)-glycoprotein 1 (anti-beta(2)GP1) antibodies for the diagnosis of antiphospholipid syndrome (APS).
7740. No difference in the incidences of vasculitides between north and south Germany: first results of the German vasculitis register.
作者: E Reinhold-Keller.;K Herlyn.;R Wagner-Bastmeyer.;J Gutfleisch.;H H Peter.;H H Raspe.;W L Gross.
来源: Rheumatology (Oxford). 2002年41卷5期540-9页
To register all newly diagnosed patients with primary systemic vasculitis (PSV) in two large regions in north and south Germany.
|